ENTEST GROUP, INC. Contracts & Agreements
63 Contracts & Agreements
- Business Finance (24 contracts)
- Business Operations (2)
- Human Resources (2)
- Real Estate (2)
- Uncategorized (33)
- STOCKPURCHASEAGREEMENT (Filed With SEC on November 20, 2018)
- ENTEST GROUP, INC. AND ZANDER THERAPEUTICS,INC. AGREEMENT (Filed With SEC on July 10, 2018)
- SUBLEASEAGREEMENT (Filed With SEC on July 10, 2018)
- COLLABORATIONAND DEVELOPMENT Agreement (Filed With SEC on July 10, 2018)
- 2018 letter agreement between Regen and Zander (Filed With SEC on April 2, 2018)
- Purchase Agreement 100,000 Shares dated 1/29/2018 (Filed With SEC on April 2, 2018)
- Purchase Agreement 50,000 Shares dated 2/22/2018 (Filed With SEC on April 2, 2018)
- Purchase Agreement 100,000 Shares dated 2/21/2018 (Filed With SEC on April 2, 2018)
- AGREEMENTBY AND BETWEEN REGEN BIOPHARMA, INC. AND ZANDER THERAPEUTICS, INC. DatedSeptember 12, 2017 (Filed With SEC on November 30, 2017)
- Exhibit10.64 AGREEMENTBY AND BETWEEN ZANDER THERAPEUTICS, INC. AND THOMAS DONNELLY (Filed With SEC on November 30, 2017)
- Exhibit10.65 AGREEMENTBY AND BETWEEN ZANDER THERAPEUTICS, INC. AND ROBIN GASSER (Filed With SEC on November 30, 2017)
- Exhibit10.66 EMPLOYMENTAGREEMENT BETWEEN ZANDERTHERAPEUTICS, INC. AND HarryM. Lander, Ph.D., M.B.A. (Filed With SEC on November 30, 2017)
- Exhibit10.67 EMPLOYMENTAGREEMENT BETWEEN ZANDERTHERAPEUTICS, INC. AND ToddS. Caven (Filed With SEC on November 30, 2017)
- Exhibit 10.68 SECURITIES PURCHASEAGREEMENT (Filed With SEC on November 30, 2017)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on October 26, 2017)
- Synergy Business Consultants Agreement executed 4/21/2017 (Filed With SEC on June 22, 2017)
- Form of Stock Purchase Agreement 500,000 shares (Filed With SEC on June 22, 2017)
- Form of Stock Purchase Agreement 250,000 shares (Filed With SEC on June 22, 2017)
- Form of Stock Purchase Agreement 8,000 shares Zander Therapeutics (Filed With SEC on June 22, 2017)
- Donnely Agreement (Filed With SEC on June 22, 2017)
- Black Agreement (Filed With SEC on June 22, 2017)
- InvestorRelations Consulting Agreement Between EntestBioMedical Inc. And Synergy Business Consultants LLC (Filed With SEC on April 3, 2017)
- ENTESTBIOMEDICAL,INC AND THOMAS E. ICHIM AGREEMENT (Filed With SEC on April 3, 2017)
- AGREEMENTBY AND BETWEEN REGEN BIOPHARMA, INC. AND ZANDER THERAPEUTICS, INC. DatedJune 15, 2016 (Filed With SEC on November 23, 2016)
- AGREEMENTBY AND BETWEEN REGEN BIOPHARMA, INC. AND ZANDER THERAPEUTICS, INC. (Filed With SEC on June 26, 2015)
- AMENDMENT TO SUBLEASE AGREEMENT(“AGREEMENT”) ENTERED INTO OCTOBER 1, 2014 BY AND BETWEEN ENTEST BIOMEDICAL, INC. ( “SUBLESSOR”) AND REGENBIOPHARMA,INC (“SUBTENANT”) (Filed With SEC on April 10, 2015)
- SUBLEASE AGREEMENT (Filed With SEC on January 13, 2015)
- SETTLEMENT AGREEMENT AND MUTUAL GENERAL RELEASE (Filed With SEC on March 12, 2013)
- CONVERTIBLE PROMISSORY NOTE (Filed With SEC on February 1, 2013)
- LINE OF CREDIT PROMISSORY NOTE (Filed With SEC on February 1, 2013)
- Agreement by and between Entest BioMedical Inc., a Nevada corporation, Entest BioMedical Inc , a California corporation, David Koos and Gregory McDonald and Pet Pointers, Inc (Filed With SEC on December 12, 2012)
- TERMS OF SALARY COMPENSATION DAVID R. KOOS (Filed With SEC on August 17, 2012)
- SECURITIES TRANSFER AGREEMENT (Filed With SEC on July 16, 2012)
- SECURITIES TRANSFER AGREEMENT (Filed With SEC on July 16, 2012)
- SECURITIES TRANSFER AGREEMENT (Filed With SEC on July 16, 2012)
- SECURITIES TRANSFER AGREEMENT (Filed With SEC on July 16, 2012)
- SECURITIES TRANSFER AGREEMENT (Filed With SEC on July 16, 2012)
- SECURITIES TRANSFER AGREEMENT (Filed With SEC on July 16, 2012)
- LINE OF CREDIT PROMISSORY NOTE (Filed With SEC on June 12, 2012)
- LINE OF CREDIT PROMISSORY NOTE (Filed With SEC on June 12, 2012)
- LINE OF CREDIT PROMISSORY NOTE (Filed With SEC on June 12, 2012)
- LINE OF CREDIT PROMISSORY NOTE (Filed With SEC on June 12, 2012)
- SECURITIES TRANSFER AGREEMENT (Filed With SEC on June 12, 2012)
- SECURITIES TRANSFER AGREEMENT (Filed With SEC on June 12, 2012)
- AMENDED 10% CONVERTIBLE NOTE (Filed With SEC on June 12, 2012)
- EQUITY PURCHASE AGREEMENT BY AND BETWEEN ENTEST BIOMEDICAL, INC. AND SOUTHRIDGE PARTNERS II, LP Dated June 1, 2012 (Filed With SEC on June 4, 2012)
- LINE OF CREDIT PROMISSORY NOTE (Filed With SEC on April 9, 2012)
- LINE OF CREDIT PROMISSORY NOTE (Filed With SEC on April 9, 2012)
- LINE OF CREDIT PROMISSORY NOTE (Filed With SEC on April 9, 2012)
- LINE OF CREDIT PROMISSORY NOTE (Filed With SEC on April 9, 2012)
- SECURITIES TRANSFER AGREEMENT (Filed With SEC on April 9, 2012)
- SECURITIES TRANSFER AGREEMENT (Filed With SEC on April 9, 2012)
- EQUITY PURCHASE AGREEMENT BY AND BETWEEN ENTEST BIOMEDICAL, INC. AND SOUTHRIDGE PARTNERS II, LP Dated February 27, 2012 (Filed With SEC on February 29, 2012)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on February 29, 2012)
- CONVERTIBLE PROMISSORY NOTE (Filed With SEC on January 11, 2012)
- EXHIBIT A (Filed With SEC on November 8, 2011)
- Escrow Agreement (Filed With SEC on February 15, 2011)
- Entest BioMedical, Inc.(Nevada)/s/ David R. KoosEntest Biomedical, Inc.David R. Koos, Chairman & CEO(California) Escrow Agent/s/ Herman H. Pettegrove Herman H. Pettegrove, Esq.... (Filed With SEC on December 27, 2010)
- Escrow Agreement (Filed With SEC on October 28, 2010)
- EXHIBIT A: (Filed With SEC on August 25, 2009)
- EXCLUSIVE LICENSEAGREEMENT (Filed With SEC on July 10, 2009)
- STOCKPURCHASE AGREEMENT (Filed With SEC on June 22, 2009)
- STOCKCANCELLATION AGREEMENT (Filed With SEC on June 22, 2009)
